Search in:

Advanced search

International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Burden of disease associated with a COPD eosinophilic phenotype

Hector Ortega1 Respiratory, US Medical Affairs, GSK, La Jolla, CA, USA

Jean-Pierre Llanos2 Respiratory, US Medical Affairs, GSK Research Triangle Park, NC, USA, [email protected]

Marie-Hélène Lafeuille3 Groupe d’analyse, Ltée, Montréal, QC, Canada

Guillaume Germain3 Groupe d’analyse, Ltée, Montréal, QC, Canada

Mei Sheng Duh4 Analysis Group, Inc., Boston, MA, USA

Christopher F Bell2 Respiratory, US Medical Affairs, GSK Research Triangle Park, NC, USA, [email protected]

Susan R Sama5 Research Department, Reliant Medical Group, Worcester, MA, USA

Beth Hahn2 Respiratory, US Medical Affairs, GSK Research Triangle Park, NC, USA, [email protected]Correspondence[email protected]

show all

Pages 2425-2433 | Published online: 13 Aug 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
PubMed Web of Science ®Google Scholar
The top 10 causes of death2017 Available from: http://www.who.int/mediacentre/factsheets/fs310/en/Accessed October 16, 2017
Google Scholar
GBD 2016 DALYs and HALE CollaboratorsGlobal, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016Lancet2017390101001260134428919118
PubMed Web of Science ®Google Scholar
FordESMurphyLBKhavjouOGilesWHHoltJBCroftJBTotal and state-specific medical and absenteeism costs of COPD among adults aged ≥18 years in the United States for 2010 and projections through 2020Chest20151471314525058738
PubMed Web of Science ®Google Scholar
SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
PubMed Web of Science ®Google Scholar
Vedel-KroghSNielsenSFLangePVestboJNordestgaardBGBlood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population StudyAm J Respir Crit Care Med2016193996597426641631
PubMed Web of Science ®Google Scholar
BrightlingCEMonteiroWWardRSputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trialLancet200035692401480148511081531
PubMed Web of Science ®Google Scholar
LeighRPizzichiniMMMorrisMMMaltaisFHargreaveFEPizzichiniEStable COPD: predicting benefit from high-dose inhaled corticosteroid treatmentEur Respir J200627596497116446316
PubMed Web of Science ®Google Scholar
SivaRGreenRHBrightlingCEEosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trialEur Respir J200729590691317301099
PubMed Web of Science ®Google Scholar
SinghDKolsumUBrightlingCEEosinophilic inflammation in COPD: prevalence and clinical characteristicsEur Respir J20144461697170025323230
PubMed Web of Science ®Google Scholar
KolsumUDameraGPhamTHPulmonary inflammation in patients with chronic obstructive pulmonary disease with higher blood eosinophil countsJ Allergy Clin Immunol2017140411811184e728506852
PubMed Web of Science ®Google Scholar
BafadhelMMckennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
PubMed Web of Science ®Google Scholar
PavordIDChanezPCrinerGJMepolizumab for Eosinophilic Chronic Obstructive Pulmonary DiseaseN Engl J Med2017377171613162928893134
PubMed Web of Science ®Google Scholar
OrtegaHGYanceySWMayerBSevere eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studiesLancet Respir Med20164754955627177493
PubMed Web of Science ®Google Scholar
PavordIDKornSHowarthPMepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialLancet2012380984265165922901886
PubMed Web of Science ®Google Scholar
BafadhelMPavordIDRussellREKEosinophils in COPD: just another biomarker?Lancet Respir Med20175974775928601554
PubMed Web of Science ®Google Scholar
HospersJJSchoutenJPWeissSTRijckenBPostmaDSAsthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sampleAm J Respir Crit Care Med199916061869187410588599
PubMed Web of Science ®Google Scholar
PavordIDLettisSLocantoreNBlood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPDThorax201671211812526585525
PubMed Web of Science ®Google Scholar
SiddiquiSHGuasconiAVestboJBlood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary DiseaseAm J Respir Crit Care Med2015192452352526051430
PubMed Web of Science ®Google Scholar
PascoeSLocantoreNDransfieldMTBarnesNCPavordIDBlood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsLancet Respir Med20153643544225878028
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Burden of disease associated with a COPD eosinophilic phenotype

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Burden of disease associated with a COPD eosinophilic phenotype

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date